Henan Kangtai Pharmaceutical Co., Ltd.

Henan Kangtai Pharmaceutical, established in 1993 near Zhengzhou in Xingyang City, Henan, was designated by the former Henan Food and Drug Administration as a specialist manufacturer of third-generation quinolone antibiotics and their intermediates, producing active pharmaceutical ingredients such as norfloxacin, gatifloxacin mesylate, fleroxacin, norfloxacin hydrochloride, and niacin from its 36,000-square-meter plant. The company's norfloxacin won the First Prize for Science and Technology Progress in Henan Province and was named a Key Project of High-tech Industrialization in Henan, while its gatifloxacin mesylate API -- a national first-class new drug -- earned the Second Prize for Science and Technology Progress in Henan and recognition among the province's Top Ten Influential Scientific and Technological Achievements; the company was certified a national high-tech enterprise in December 2022 and recognized as a Xingyang Excellent Private Enterprise in 2023. It offers CRO contract services and exports its APIs worldwide, trading on its brand, experienced R&D team, and willingness to accommodate buyers' specifications.